| מסגרת זמן | מחיר חזוי | עָבָר | הִיסטוֹרִי | תוֹבָנָה |
|---|---|---|---|---|
| מָחָר | $569.49 ▼ -0.69% | אֶתמוֹל | $575.13 ▲ +0.29% | Tomorrow's United Therapeutics Corporation Common Stock (UTHR) setup is anchored to $573.46 and targets $569.49 (-0.69%). The near-term read is downside; watch $590.66 / $556.26 because daily realized volatility is about 3.57%. |
Tomorrow's United Therapeutics Corporation Common Stock (UTHR) setup is anchored to $573.46 and targets $569.49 (-0.69%). The near-term read is downside; watch $590.66 / $556.26 because daily realized volatility is about 3.57%. | ||||
| שָׁבוּעַ | $561.10 ▼ -2.16% | שבוע שעבר | $578.65 ▲ +0.91% | The 7-day United Therapeutics Corporation Common Stock model moves from $578.65 to $561.10 (-2.16%). It gives downside momentum context for this stock, so breaks around $590.66 / $556.26 matter more than a single tick. |
The 7-day United Therapeutics Corporation Common Stock model moves from $578.65 to $561.10 (-2.16%). It gives downside momentum context for this stock, so breaks around $590.66 / $556.26 matter more than a single tick. | ||||
| חוֹדֶשׁ | $547.13 ▼ -4.59% | חודש שעבר | $584.52 ▲ +1.93% | The 1-month United Therapeutics Corporation Common Stock target is $547.13 (-4.59%), compared with the live reference near $573.46. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month United Therapeutics Corporation Common Stock target is $547.13 (-4.59%), compared with the live reference near $573.46. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| שָׁנָה | $526.19 ▼ -8.24% | אֶשׁתָקַד | $593.31 ▲ +3.46% | The 1-year United Therapeutics Corporation Common Stock scenario points to $526.19 (-8.24%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year United Therapeutics Corporation Common Stock scenario points to $526.19 (-8.24%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 שנים | $477.12 ▼ -16.80% | לפני 5 שנים | $613.92 ▲ +7.06% | The 5-year United Therapeutics Corporation Common Stock view is $477.12 (-16.80%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year United Therapeutics Corporation Common Stock view is $477.12 (-16.80%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| מַד | עֵרֶך | אוֹת |
|---|---|---|
| Price | $573.46 | Mid |
| Daily Change | +0.00% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 57% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $573.46 | Daily Change | +0.00% |
| Market Cap | $25.13B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.